Beta-2 Microglobulin Predicts The Outcome After Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma

被引:0
|
作者
Atesoglu, E. Birtas [1 ]
Hacihanefioglu, A. [1 ]
Gulbas, Z. [2 ]
机构
[1] Kocaeli Univ, Dept Hematol, Kocaeli, Turkey
[2] Anadolu Med Ctr Hosp, Bone Marrow Transplantat Ctr, Kocaeli, Turkey
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
AB147
引用
收藏
页码:5618 / 5618
页数:1
相关论文
共 50 条
  • [41] Autologous hematopoietic stem cell transplantation with inadequate stem cell dose in patients with non-Hodgkin lymphoma
    Liu, Weiping
    Wu, Meng
    Xie, Yan
    Zhang, Chen
    Ping, Lingyan
    Feng, Feier
    Leng, Xin
    Mi, Lan
    Wang, Xiaopei
    Zhu, Jun
    Song, Yuqin
    LEUKEMIA & LYMPHOMA, 2021, 62 (02) : 323 - 329
  • [42] Laboratory and imaging markers for prediction of outcome in aggressive non-hodgkin lymphoma undergoing autologous stem cell transplantation
    Pilar Gonzalez-Rodriguez, Ana
    Zanabili, Joud
    Palomo, Pilar
    Julia Gonzalez-Huerta, Ana
    Menendez Parron, Aida
    Zambrano, Javier
    Gonzalez-Muniz, Soledad
    BONE MARROW TRANSPLANTATION, 2019, 54 : 462 - 463
  • [43] HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma (NHL)
    Krishnan, Amrita
    Palmer, Joycelynne M.
    Zaia, John A.
    Tsai, Ni-Chun
    Alvarnas, Joseph
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (09) : 1302 - 1308
  • [44] Outcome of autologous stem cell transplantation on aggressive non-Hodgkin lymphoma- a single center retrospective analysis
    Liu, Y.
    Chen, X. -H.
    Jia-Li, J. -L.
    Zhang, C.
    Gao, L.
    Gao, L.
    Zhang, X.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S604 - S604
  • [45] Autologous stem cell transplantation improve outcome in non-Hodgkin's lymphoma: results of a computer science analysis
    Pelosini, M.
    Baronti, F.
    Galimberti, S.
    Caracciolo, F.
    Benedetti, E.
    Papineschi, F.
    Starita, A.
    Petrini, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S212 - S213
  • [46] A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
    Merrill, Mwanasha H.
    Dahi, Parastoo B.
    Redd, Robert A.
    Mcdonough, Mikaela M.
    Chen, Yi-Bin
    Defilipp, Zachariah
    Herrera, Alex F.
    Fisher, David C.
    Lacasce, Ann S.
    Odejide, Oreofe O.
    Ng, Samuel Y.
    Jacobson, Caron A.
    Merryman, Reid W.
    Kim, Austin I.
    Nieto, Yago L.
    Sauter, Craig S.
    Shah, Gunjan L.
    Zain, Jasmine M.
    Armand, Philippe
    Jacobsen, Eric D.
    BLOOD, 2023, 142 (07) : 621 - 628
  • [47] Beta-2 Microglobulin as a Diagnostic Parameter in Non-Hodgkin Lymphoma: A Comparative Study with FDG-PET
    Toth, Daniel F.
    Raderer, Markus
    Wadsak, Wolfgang
    Karanikas, Georgios
    ANTICANCER RESEARCH, 2013, 33 (08) : 3341 - 3345
  • [48] Comorbidity at Relapse Is An Independent Predictor for Eligibility and Outcome of Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma
    Plattel, Wouter J.
    Kluin-Nelemans, Hanneke C.
    de Bock, Geertruida H.
    van Imhoff, Gustaaf
    BLOOD, 2009, 114 (22) : 914 - 914
  • [49] The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma
    Osmanilhan
    Seval, Guldane Cengiz
    Bozdag, Sinem Civriz
    Toprak, Selami kocak
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Gurman, Gunhan
    Beksac, Meral
    BLOOD, 2021, 138
  • [50] Stem-cell transplantation in non-Hodgkin's lymphoma:: improving outcome
    Gianni, AM
    Berinstein, NL
    Evans, PAS
    López-Guillermo, A
    Solano, C
    ANTI-CANCER DRUGS, 2002, 13 : S35 - S42